Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary Adherence
- PMID: 38474766
- PMCID: PMC10933964
- DOI: 10.3390/nu16050639
Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary Adherence
Abstract
Supplementation is crucial for improving performance and health in phenylketonuria (PKU) patients, who face dietary challenges. Proteins are vital for athletes, supporting muscle growth, minimizing catabolism, and aiding muscle repair and glycogen replenishment post-exercise. However, PKU individuals must limit phenylalanine (Phe) intake, requiring supplementation with Phe-free amino acids or glycomacropeptides. Tailored to meet nutritional needs, these substitutes lack Phe but fulfill protein requirements. Due to limited supplement availability, athletes with PKU may need higher protein intake. Various factors affect tolerated Phe levels, including supplement quantity and age. Adhering to supplement regimens optimizes performance and addresses PKU challenges. Strategically-timed protein substitutes can safely enhance muscle synthesis and sports performance. Individualized intake is essential for optimal outcomes, recognizing proteins' multifaceted role. Here, we explore protein substitute supplementation in PKU patients within the context of physical activity, considering limited evidence.
Keywords: adherence; amino acid; glycomacropetides; phenyalanine; phenylketonuria; physical activity; protein substitutes; supplement regimens; tyrosine.
Conflict of interest statement
The participation of C.M., an expert in PKU supplements from Nutricia-Danone, does not influence the content of the article nor have any commercial interest.
Similar articles
-
Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.Nutr Res Rev. 2019 Jun;32(1):70-78. doi: 10.1017/S0954422418000173. Epub 2018 Oct 4. Nutr Res Rev. 2019. PMID: 30284526 Free PMC article. Review.
-
A series of three case reports in patients with phenylketonuria performing regular exercise: first steps in dietary adjustment.J Pediatr Endocrinol Metab. 2019 Jun 26;32(6):635-641. doi: 10.1515/jpem-2018-0492. J Pediatr Endocrinol Metab. 2019. PMID: 31112507
-
Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.J Nutr. 2008 Feb;138(2):316-22. doi: 10.1093/jn/138.2.316. J Nutr. 2008. PMID: 18203898
-
The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.PLoS One. 2022 Jan 11;17(1):e0261150. doi: 10.1371/journal.pone.0261150. eCollection 2022. PLoS One. 2022. PMID: 35015767 Free PMC article.
-
Casein glycomacropeptide in phenylketonuria: does it bring clinical benefit?Curr Opin Clin Nutr Metab Care. 2024 Jan 1;27(1):31-39. doi: 10.1097/MCO.0000000000001000. Epub 2023 Dec 14. Curr Opin Clin Nutr Metab Care. 2024. PMID: 38085662 Review.
References
-
- van Wegberg A.M.J., MacDonald A., Ahring K., Bélanger-Quintana A., Blau N., Bosch A.M., Burlina A., Campistol J., Feillet F., Giżewska M., et al. The complete European guidelines on phenylketonuria: Diagnosis and treatment. Orphanet J. Rare Dis. 2017;12:162. doi: 10.1186/s13023-017-0685-2. - DOI - PMC - PubMed
-
- Dietary Supplement Health and Education Act of 1994. Public Law 103–417, 103rd Congress. [(accessed on 3 February 2024)]; Available online: https://www.congress.gov/bill/103rd-congress/senate-bill/784#.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical